CN114344341B - 具有调节肠道作用的复合益生菌组合物及制备方法和应用 - Google Patents
具有调节肠道作用的复合益生菌组合物及制备方法和应用 Download PDFInfo
- Publication number
- CN114344341B CN114344341B CN202210071747.0A CN202210071747A CN114344341B CN 114344341 B CN114344341 B CN 114344341B CN 202210071747 A CN202210071747 A CN 202210071747A CN 114344341 B CN114344341 B CN 114344341B
- Authority
- CN
- China
- Prior art keywords
- parts
- bifidobacterium
- probiotic composition
- composite
- weight ratio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 92
- 239000006041 probiotic Substances 0.000 title claims abstract description 62
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 62
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 56
- 239000002131 composite material Substances 0.000 title claims abstract description 50
- 210000001035 gastrointestinal tract Anatomy 0.000 title claims abstract description 24
- 230000001105 regulatory effect Effects 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title claims description 20
- 241000894006 Bacteria Species 0.000 claims abstract description 37
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 30
- 239000005017 polysaccharide Substances 0.000 claims abstract description 30
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 28
- 239000003223 protective agent Substances 0.000 claims abstract description 25
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims abstract description 18
- 241000191996 Pediococcus pentosaceus Species 0.000 claims abstract description 18
- 241001608472 Bifidobacterium longum Species 0.000 claims abstract description 14
- 241000194020 Streptococcus thermophilus Species 0.000 claims abstract description 14
- 229940009291 bifidobacterium longum Drugs 0.000 claims abstract description 14
- 150000004676 glycans Chemical class 0.000 claims abstract description 14
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 13
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 13
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 12
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 12
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 12
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 10
- 239000004310 lactic acid Substances 0.000 claims abstract description 10
- -1 compound polysaccharide Chemical class 0.000 claims description 19
- 229920002678 cellulose Polymers 0.000 claims description 11
- 239000001913 cellulose Substances 0.000 claims description 11
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 claims description 11
- 229920001661 Chitosan Polymers 0.000 claims description 10
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 10
- 229940045110 chitosan Drugs 0.000 claims description 10
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 10
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 10
- 229960000511 lactulose Drugs 0.000 claims description 10
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 claims description 10
- 239000000600 sorbitol Substances 0.000 claims description 10
- RQFQJYYMBWVMQG-IXDPLRRUSA-N chitotriose Chemical compound O[C@@H]1[C@@H](N)[C@H](O)O[C@H](CO)[C@H]1O[C@H]1[C@H](N)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)[C@@H](CO)O1 RQFQJYYMBWVMQG-IXDPLRRUSA-N 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000000843 powder Substances 0.000 claims description 8
- 241000186660 Lactobacillus Species 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 4
- 239000008267 milk Substances 0.000 claims description 4
- 210000004080 milk Anatomy 0.000 claims description 4
- 239000003814 drug Substances 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 2
- 230000006870 function Effects 0.000 abstract description 15
- 206010010774 Constipation Diseases 0.000 abstract description 13
- 206010012735 Diarrhoea Diseases 0.000 abstract description 13
- 238000010521 absorption reaction Methods 0.000 abstract description 13
- 230000029087 digestion Effects 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 11
- 230000000968 intestinal effect Effects 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 230000000052 comparative effect Effects 0.000 description 33
- 238000012360 testing method Methods 0.000 description 20
- 241000699670 Mus sp. Species 0.000 description 10
- 230000013872 defecation Effects 0.000 description 8
- 241000699666 Mus <mouse, genus> Species 0.000 description 7
- 230000009286 beneficial effect Effects 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 230000008569 process Effects 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 3
- 241000186672 Lactobacillus delbrueckii subsp. bulgaricus Species 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 235000013350 formula milk Nutrition 0.000 description 3
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- OCKGFTQIICXDQW-ZEQRLZLVSA-N 5-[(1r)-1-hydroxy-2-[4-[(2r)-2-hydroxy-2-(4-methyl-1-oxo-3h-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3h-2-benzofuran-1-one Chemical compound C1=C2C(=O)OCC2=C(C)C([C@@H](O)CN2CCN(CC2)C[C@H](O)C2=CC=C3C(=O)OCC3=C2C)=C1 OCKGFTQIICXDQW-ZEQRLZLVSA-N 0.000 description 2
- 241000192001 Pediococcus Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 229960004192 diphenoxylate Drugs 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 210000003608 fece Anatomy 0.000 description 2
- 230000007661 gastrointestinal function Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000012827 research and development Methods 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000193171 Clostridium butyricum Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 241000235342 Saccharomycetes Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000021316 daily nutritional intake Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 230000008821 health effect Effects 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
试验样品 | 小鼠初重 | 小鼠终重 | 平均日增重 | 日摄食量 | 食物利用率 |
实施例1 | 147.85 | 290.85g | 7.15g | 19.58g | 0.36 |
实施例2 | 132.61 | 276.81g | 7.21g | 19.49g | 0.37 |
实施例3 | 154.55 | 301.35g | 7.34g | 18.35g | 0.40 |
对比例1 | 142.38 | 277.38g | 6.75g | 21.77g | 0.31 |
对比例2 | 160.62 | 284.02g | 6.17g | 25.71g | 0.24 |
对比例3 | 139.18 | 275.98g | 6.84g | 24.42g | 0.28 |
对比例4 | 152.37 | 279.97g | 6.35g | 23.50g | 0.27 |
对比例5 | 167.15 | 301.75g | 6.73g | 21.71g | 0.31 |
对比例6 | 159.88 | 298.08g | 6.91g | 21.59g | 0.32 |
对比例7 | 163.25 | 292.25 | 6.45 | 20.79 | 0.31 |
对比例8 | 149.78 | 271.98 | 6.11 | 21.08 | 0.29 |
阴性对照组 | 165.33 | 286.53g | 6.06g | 26.35g | 0.23 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210071747.0A CN114344341B (zh) | 2022-01-21 | 2022-01-21 | 具有调节肠道作用的复合益生菌组合物及制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210071747.0A CN114344341B (zh) | 2022-01-21 | 2022-01-21 | 具有调节肠道作用的复合益生菌组合物及制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114344341A CN114344341A (zh) | 2022-04-15 |
CN114344341B true CN114344341B (zh) | 2022-09-16 |
Family
ID=81091671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210071747.0A Active CN114344341B (zh) | 2022-01-21 | 2022-01-21 | 具有调节肠道作用的复合益生菌组合物及制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114344341B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114504623A (zh) * | 2022-04-19 | 2022-05-17 | 广东益可维生物技术有限公司 | 改善气虚型便秘的中药益生菌复合制品及其制备方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109718289A (zh) * | 2019-01-07 | 2019-05-07 | 云浮市新金山生物科技股份有限公司 | 一种治疗或预防胃肠道疾病的低聚半乳糖益生元组合物 |
CN110151796A (zh) * | 2019-05-09 | 2019-08-23 | 中科宜康(北京)生物科技有限公司 | 一种形成易瘦体质的益生菌和益生元组合物及其应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1481681A1 (en) * | 2003-05-30 | 2004-12-01 | Claudio De Simone | Lactic acid bacteria combination and compositions thereof |
EP4165999A1 (en) * | 2013-12-11 | 2023-04-19 | DuPont Nutrition Biosciences ApS | A method for preparing a dairy product having a stable content of galacto-oligosaccharide(s) |
CN104824662B (zh) * | 2015-04-10 | 2017-10-13 | 圣原健康产业有限公司 | 具调节肠道菌群功能的乳酸菌组合物及其制备方法与应用 |
CN106616586A (zh) * | 2016-10-14 | 2017-05-10 | 千亿达(天津)科技有限公司 | 一种肠胃保健益生菌粉 |
CN109619596A (zh) * | 2019-01-28 | 2019-04-16 | 江西美好时光生物科技有限公司 | 一种调理便秘的益生菌粉及其制备方法 |
CN113575963A (zh) * | 2021-08-04 | 2021-11-02 | 北大荒完达山乳业股份有限公司 | 一种低聚糖益生菌组合物及其制备方法 |
CN113662996A (zh) * | 2021-08-25 | 2021-11-19 | 广州市沐家健康产业有限公司 | 具有减肥作用的益生菌组合物及其制备方法 |
-
2022
- 2022-01-21 CN CN202210071747.0A patent/CN114344341B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109718289A (zh) * | 2019-01-07 | 2019-05-07 | 云浮市新金山生物科技股份有限公司 | 一种治疗或预防胃肠道疾病的低聚半乳糖益生元组合物 |
CN110151796A (zh) * | 2019-05-09 | 2019-08-23 | 中科宜康(北京)生物科技有限公司 | 一种形成易瘦体质的益生菌和益生元组合物及其应用 |
Also Published As
Publication number | Publication date |
---|---|
CN114344341A (zh) | 2022-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104758318B (zh) | 一种降低断奶仔猪腹泻率的复合制剂及其制备方法 | |
US8551473B2 (en) | Metabolically active micro organisms and methods for their production | |
DE60316772T2 (de) | Von menschen oder tieren verwendbare diätetische und/oder pharmazeutische zubereitungen auf basis von probiotischen mikroorganismen | |
CN104642870B (zh) | 一种益生元组合物 | |
CN106619743A (zh) | 一种具有降血糖作用的益生菌固体饮料及其制备方法 | |
Zduńczyk et al. | Determinants and effects of postileal fermentation in broilers and turkeys part 1: gut microbiota composition and its modulation by feed additives | |
CN109619540A (zh) | 一种具有润肠通便作用的益生菌组合物及其制备方法和应用 | |
CN108740251A (zh) | 一种改善便秘的益生菌凝胶糖果及其制备方法 | |
CN105685970A (zh) | 一种全消化道改善的复合营养食品 | |
CN109475151A (zh) | 控制肠道微生物群中有害细菌的免疫调节和促生长组合物及其用途 | |
CN105942527A (zh) | 一种益生菌和益生元复合制剂及其制备方法和应用 | |
CN108283285A (zh) | 一种糖尿病的理疗保健食品 | |
CN108402320A (zh) | 一种复合益生菌制剂及其在仔猪饲料中的应用 | |
CN109315769A (zh) | 一种用于改善人体肠内环境的组合物及其制备方法 | |
CN106689753A (zh) | 断乳仔猪饲用复合制剂、含其饲料和应用 | |
CN107772195A (zh) | 一种畜禽用饲料脱霉剂及其制备方法 | |
CN114344341B (zh) | 具有调节肠道作用的复合益生菌组合物及制备方法和应用 | |
KR100923226B1 (ko) | 항균효과가 강화된 사료첨가용 유산균제제 와 그 제조방법 | |
CN111035661A (zh) | 植物乳杆菌的用途 | |
CN105995443B (zh) | 一种婴幼儿益肠营养米粉及其制备方法 | |
Simsek et al. | Effects of dietary various supplementations on the mucin-and serotonin-releasing cell numbers in small intestine of quails | |
CN109329583A (zh) | 一种肉鸡饲料 | |
CN111603489A (zh) | 一种改善便秘的菌剂及其制备方法 | |
CN105995147A (zh) | 一种肉仔鸡无抗日粮饲料添加剂预混料及其使用方法 | |
Dhruw et al. | Effect of Live Lactobacillus acidophilus NCDC 15 and CURD as probiotics on blood biochemical profile of early weaned piglets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Room 409, 4th Floor, No. 3, Yiheng Road, Datian, Hebian, Hebian, Helong Street, Baiyun District, Guangzhou City, Guangdong Province, 510000 Applicant after: Guangzhou Bafeiba Health Industry Co.,Ltd. Address before: 510440 room 913, floor 9, No. 629, Helong 1st Road, Helong street, Baiyun District, Guangzhou, Guangdong Applicant before: Guangzhou Mujia Health Industry Co.,Ltd. |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240312 Address after: 236000, Room 315, 2.5 Industrial Park, Bowu Modern Industrial Park, Hehuan Road, High tech Zone, Bozhou City, Anhui Province Patentee after: Bafeiba Food Technology Co.,Ltd. Country or region after: China Address before: Room 409, 4th Floor, No. 3, Yiheng Road, Datian, Hebian, Hebian, Helong Street, Baiyun District, Guangzhou City, Guangdong Province, 510000 Patentee before: Guangzhou Bafeiba Health Industry Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |